Val-Ala-PAB -SN38 is a drug-linker conjugate for ADC , composed of ADC linker Val-Ala-PAB ( HY-125933 ) and SN38 ( HY-13704 ), which is the active metabolite of the Topoisomerase I inhibitor Irinotecan ( HY-16562 ).
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Drug-Linker Conjugates for ADC
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.